$PROCEPT BioRobotics (PRCT.US)$
Which genius is also Bullish on PRCT's Earnings Reports after hours? 🤔🤔🤔
Which genius is also Bullish on PRCT's Earnings Reports after hours? 🤔🤔🤔
Translated
$PROCEPT BioRobotics (PRCT.US)$
Procept BioRobotics Corporation (Nasdaq Code: PRCT) is a company focused on developing robotic surgical systems for the treatment of Benign Prostatic Hyperplasia (BPH). Its flagship product, Aquablation, is a minimally invasive procedure designed to provide effective treatment options for BPH patients.
In the last Earnings Reports: In the third quarter of 2024, Procept BioRobotics' sales increased by 66% year-on-year, reaching $58.4 million, exceeding market expectations. Although the company is still operating at a loss, the loss per share has narrowed to $0.40, better than Analyst expectations. Additionally, the company added 45 new Aquablation systems in the USA market, an 18% increase from the previous quarter. Based on these positive performances, the company has raised its full-year sales outlook to between $0.2225 billion and $0.223 billion.
William Blair Analyst Brandon Vazquez holds an optimistic view of Procept BioRobotics, believing that strong market demand, the launch of new products, improved profitability, and increased market penetration are key drivers for the company's future growth. He reiterated a "outperform Large Cap" rating for the company.
Overall, Procept BioRobotics stands out among mid-cap growth stocks, with its innovative...
Procept BioRobotics Corporation (Nasdaq Code: PRCT) is a company focused on developing robotic surgical systems for the treatment of Benign Prostatic Hyperplasia (BPH). Its flagship product, Aquablation, is a minimally invasive procedure designed to provide effective treatment options for BPH patients.
In the last Earnings Reports: In the third quarter of 2024, Procept BioRobotics' sales increased by 66% year-on-year, reaching $58.4 million, exceeding market expectations. Although the company is still operating at a loss, the loss per share has narrowed to $0.40, better than Analyst expectations. Additionally, the company added 45 new Aquablation systems in the USA market, an 18% increase from the previous quarter. Based on these positive performances, the company has raised its full-year sales outlook to between $0.2225 billion and $0.223 billion.
William Blair Analyst Brandon Vazquez holds an optimistic view of Procept BioRobotics, believing that strong market demand, the launch of new products, improved profitability, and increased market penetration are key drivers for the company's future growth. He reiterated a "outperform Large Cap" rating for the company.
Overall, Procept BioRobotics stands out among mid-cap growth stocks, with its innovative...
Translated
$PROCEPT BioRobotics (PRCT.US)$
It was announced today that the financial results for the fourth quarter of 2024 will be released after the market closes on Tuesday, February 25, 2025. The company's management will hold a corresponding conference call starting at 4:30 PM Eastern Time.
Is it time to buy at this price? Waiting for the rush of the Earnings Reports …..🧐🤔
It was announced today that the financial results for the fourth quarter of 2024 will be released after the market closes on Tuesday, February 25, 2025. The company's management will hold a corresponding conference call starting at 4:30 PM Eastern Time.
Is it time to buy at this price? Waiting for the rush of the Earnings Reports …..🧐🤔
Translated
$PROCEPT BioRobotics (PRCT.US)$
Does anyone know when PRCT will release its Earnings Reports this time?
Does anyone know when PRCT will release its Earnings Reports this time?
Translated
1
$PROCEPT BioRobotics (PRCT.US)$
Spruce Point Capital Management is an investment management company based in the USA, known for short-selling researchand activist investing. Led by aggressive investment strategies.Founded by Ben Axler Founded in 2009, the company is known for its in-depth financial analysis and investigative research, often publicly questioning the financial situation or business model of listed companies. Here is detailed information about the company:
Main Business and Characteristics
1. Focus on short selling.：
• Spruce Point Capital mainly publishes negative research reports on listed companies, which usually question the target company's financial data, governance structure, or business prospects.
• Through these reports, the company is trying to drive down the market prices of these companies in order to profit from short selling trades.
2. Aggressive investors：
• The company not only limits itself to short selling, but may also confront the company when management issues are discovered, demanding governance improvements.
3. Industry coverage：
• It involves a wide range of industries, including Technology, Consumer, Medical, etc. The target is typically companies with relatively small market cap but high valuation or potential issues.
4. Analysis Methods：
• Based on in-depth due diligence, integrating public financial data, market research, specialized...
Spruce Point Capital Management is an investment management company based in the USA, known for short-selling researchand activist investing. Led by aggressive investment strategies.Founded by Ben Axler Founded in 2009, the company is known for its in-depth financial analysis and investigative research, often publicly questioning the financial situation or business model of listed companies. Here is detailed information about the company:
Main Business and Characteristics
1. Focus on short selling.：
• Spruce Point Capital mainly publishes negative research reports on listed companies, which usually question the target company's financial data, governance structure, or business prospects.
• Through these reports, the company is trying to drive down the market prices of these companies in order to profit from short selling trades.
2. Aggressive investors：
• The company not only limits itself to short selling, but may also confront the company when management issues are discovered, demanding governance improvements.
3. Industry coverage：
• It involves a wide range of industries, including Technology, Consumer, Medical, etc. The target is typically companies with relatively small market cap but high valuation or potential issues.
4. Analysis Methods：
• Based on in-depth due diligence, integrating public financial data, market research, specialized...
Translated
$PROCEPT BioRobotics (PRCT.US)$
$78 Is it the time to increase positions?
$78 Is it the time to increase positions?
Translated
Where can historical price information be added with the execution date instead of the order date? Thank you.
Translated
$PROCEPT BioRobotics (PRCT.US)$
Will it rise to how much, exceeding 100 to 112?
Will it rise to how much, exceeding 100 to 112?
Translated
1
$Bakkt Holdings (BKKT.US)$
The stock price of Bakkt Holdings (BKKT) recently rose, and the company announced two financing plans: the first is to directly issue value to institutional investors 40 million dollars The second is to conduct a project with the Intercontinental Exchange (ICE) 10 million dollars ancillary financing. These funds will be used for general corporate purposes and working capital. The news boosted investors' confidence, thereby driving the stock price higher
The stock price of Bakkt Holdings (BKKT) recently rose, and the company announced two financing plans: the first is to directly issue value to institutional investors 40 million dollars The second is to conduct a project with the Intercontinental Exchange (ICE) 10 million dollars ancillary financing. These funds will be used for general corporate purposes and working capital. The news boosted investors' confidence, thereby driving the stock price higher
Translated
1
1
$Bakkt Holdings (BKKT.US)$ Is it rising because of BTC or DJT? Does anyone know?
Translated
1
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)